# Trade Mark Journal No.2026/012 20 March 2026

## WO0000001905902 (5,44)

Office of origin: Switzerland

Date of International Registration:17 December 2025
Date of designation in the UK: 17 December 2025

International priority date claimed: 10 October 2025 (Switzerland) (840022)

Class 5
  Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders.
Class 44
  Providing medical information via a website.

Incyte Holdings Corporation

Representative: Schaad Balass Menzl & Partner AG Patent- and Trademark Attorneys, Bellerivestrasse 20, CH-8034 Zürich, SWITZERLAND